McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–35.
CAS
Google Scholar
Halperin EC, Perez CA, Brady LW. Perez and Brady’s principles and practice of radiation oncology. 5th ed. Philadelphia: LWW; 2008.
Google Scholar
Wang J, Li X, Deng Q, Xia B, Wu S, Liu J, Ma S. Postoperative radiotherapy following mastectomy for patients with left-sided breast cancer: a comparative dosimetric study. Med Dosim. 2015;40:190–4.
PubMed
Google Scholar
Nichols GP, Fontenot JD, Gibbons JP, Sanders ME. Evaluation of volumetric modulated arc therapy for postmastectomy treatment. Radiat Oncol. 2014;9:66.
PubMed
PubMed Central
Google Scholar
Xie Y, Bourgeois D, Guo B, Zhang R. Post-mastectomy radiotherapy for left-sided breast cancer patients: comparison of advanced techniques. Med Dosimetry. 2020;45(1):34–40.
Google Scholar
Opp D, Forster K, Li W, Zhang G, Harris EE. Evaluation of bolus electron conformal therapy compared with conventional techniques for the treatment of left chest wall postmastectomy in patients with breast cancer. Med Dosim. 2013;38:448–53.
PubMed
Google Scholar
Zhang R, Heins D, Sanders M, Guo B, Hogstrom K. Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy. Med Phys. 2018;45:2912–24.
CAS
PubMed
PubMed Central
Google Scholar
Hernandez M, Zhang R, Sanders ME, Newhauser W. A treatment planning comparison of volumetric modulated arc therapy and proton therapy for a sample of breast cancer patients treated with post-mastectomy radiotherapy. Jour Proton Ther. 2015;1:119.
Google Scholar
Ruben JD, Smith R, Lancaster CM, Haynes M, Jones P, Panettieri V. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis. Int J Radiat Oncol Biol Phys. 2014;90:645–53.
PubMed
Google Scholar
Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003;56:83–8.
PubMed
Google Scholar
Hojris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet. 1999;354:1425–30.
CAS
PubMed
Google Scholar
Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, Correa C, Cutter D, Gagliardi G, Gigante B, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–98.
CAS
PubMed
Google Scholar
Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56:1038–45.
PubMed
Google Scholar
Lind PA, Marks LB, Hardenbergh PH, Clough R, Fan M, Hollis D, Hernando ML, Lucas D, Piepgrass A, Prosnitz LR. Technical factors associated with radiation pneumonitis after local ± regional radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52:137–43.
PubMed
Google Scholar
Neugut AI, Robinson E, Lee WC, Murray T, Karwoski K, Kutcher GJ. Lung cancer after radiation therapy for breast cancer. Cancer. 1993;71:3054–7.
CAS
PubMed
Google Scholar
Grantzau T, Mellemkjaer L, Overgaard J. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol. 2013;106:42–9.
PubMed
Google Scholar
The costs of breast cancer in the U.S. https://costsofcare.org/the-costs-of-breast-cancer-in-the-u-s/. Accessed 1 Aug 2020.
Lee JH, Glick HA, Hayman JA, Solin LJ. Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients. J Clin Oncol. 2002;20:2713–25.
PubMed
Google Scholar
Marks LB, Hardenbergh PH, Winer ET, Prosnitz LR. Assessing the cost-effectiveness of postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:91–8.
CAS
PubMed
Google Scholar
Grosse SD. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res. 2008;8:165–78.
PubMed
Google Scholar
Neumann PJ. What next for QALYs? JAMA. 2011;305:1806–7.
CAS
PubMed
Google Scholar
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.
CAS
PubMed
Google Scholar
Colzani E, Johansson AL, Liljegren A, Foukakis T, Clements M, Adolfsson J, Hall P, Czene K. Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics. Br J Cancer. 2014;110:1378–84.
CAS
PubMed
PubMed Central
Google Scholar
Jeba J, Isiah R, Subhashini J, Backianathan S, Thangakunam B, Christopher DJ. Radiation pneumonitis after conventional radiotherapy for breast cancer: a prospective study. J Clin Diagn Res. 2015;9:XC01–5.
CAS
PubMed
PubMed Central
Google Scholar
Henson KE, McGale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108:179–82.
CAS
PubMed
Google Scholar
Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor RK. Second primary in the contralateral breast after treatment of breast cancer. Radiother Oncol. 2008;86:171–6.
PubMed
Google Scholar
Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, Dodwell D, Ewertz M, Gray R, Jagsi R, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35:1641–9.
PubMed
PubMed Central
Google Scholar
Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, Henning GT, Hayman JA, Martel MK, Ten Haken RK. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys. 2003;55:724–35.
PubMed
Google Scholar
National Research Council. Health risks from exposure to low levels of ionizing radation: BEIR VII—Phase 2. Washington, DC: The National Academies Press; 2006.
Google Scholar
Arias E, Xu J. United States life tables, 2015. Natl Vital Stat Rep. 2018;67:1–64.
PubMed
Google Scholar
Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611–9.
CAS
PubMed
Google Scholar
Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer. 2004;91:868–72.
CAS
PubMed
PubMed Central
Google Scholar
Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
Google Scholar
Briggs A. Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value Health. 2005;8:1–2.
PubMed
Google Scholar
Lundkvist J, Ekman M, Ericsson SR, Isacsson U, Jonsson B, Glimelius B. Economic evaluation of proton radiation therapy in the treatment of breast cancer. Radiother Oncol. 2005;75:179–85.
PubMed
Google Scholar
Mailhot Vega RB, Ishaq O, Raldow A, Perez CA, Jimenez R, Scherrer-Crosbie M, Bussiere M, Taghian A, Sher DJ, MacDonald SM. Establishing cost-effective allocation of proton therapy for breast irradiation. Int J Radiat Oncol Biol Phys. 2016;95:11–8.
PubMed
Google Scholar
Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316:1093–103.
PubMed
Google Scholar
Sher DJ, Tishler RB, Pham NL, Punglia RS. Cost-effectiveness analysis of intensity modulated radiation therapy versus proton therapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2018;101:875–82.
PubMed
Google Scholar
Eldeeb H, Awad I, Elhanafy O. Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up. Med Oncol. 2012;29:2570–6.
PubMed
Google Scholar
Dore M, Cutuli B, Cellier P, Campion L, Le Blanc M. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : analysis of 205 cases. Radiat Oncol. 2015;10:161.
PubMed
PubMed Central
Google Scholar
Mortimer JW, McLachlan CS, Hansen CJ, Assareh H, Last A, McKay MJ, Shakespeare TP. Use of hypofractionated post-mastectomy radiotherapy reduces health costs by over $2000 per patient: an Australian perspective. J Med Imaging Radiat Oncol. 2016;60:146–53.
PubMed
Google Scholar
Lievens Y. Hypofractionated breast radiotherapy: financial and economic consequences. Breast. 2010;19:192–7.
PubMed
Google Scholar
Sullivan PW, Ghushchyan V. Preference-BASED EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26:410–20.
PubMed
PubMed Central
Google Scholar
Sturza J. A review and meta-analysis of utility values for lung cancer. Med Decis Making. 2010;30:685–93.
PubMed
Google Scholar
Stokes ME, Thompson D, Montoya EL, Weinstein MC, Winer EP, Earle CC. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data. Value Health. 2008;11:213–20.
PubMed
Google Scholar
Roberts ET, Horne A, Martin SS, Blaha MJ, Blankstein R, Budoff MJ, Sibley C, Polak JF, Frick KD, Blumenthal RS, Nasir K. Cost-effectiveness of coronary artery calcium testing for coronary heart and cardiovascular disease risk prediction to guide statin allocation: the Multi-Ethnic Study of Atherosclerosis (MESA). PLoS ONE. 2015;10:e0116377.
PubMed
PubMed Central
Google Scholar
Roberts A, Habibi M, Frick KD. Cost-effectiveness of contralateral prophylactic mastectomy for prevention of contralateral breast cancer. Ann Surg Oncol. 2014;21:2209–17.
PubMed
Google Scholar
Andreas S, Chouaid C, Danson S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue MH, Barth J, Hoffmann H, Potter V, et al. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: a retrospective observational study (LuCaBIS). Lung Cancer. 2018;124:298–309.
PubMed
Google Scholar
Schwarzkopf L, Wacker M, Holle R, Leidl R, Gunster C, Adler JB, Huber RM. Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens. Lung Cancer. 2015;90:274–80.
PubMed
Google Scholar
Keusters WR, de Weger VA, Hovels A, Schellens JHM, Frederix GWJ. Changing costs of metastatic non small cell lung cancer in the Netherlands. Lung Cancer. 2017;114:56–61.
CAS
PubMed
Google Scholar